⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Francois Schramek Promoted to Partner at Manhattan West
prnewswire.com
AI
AMN
GM
LMT
NVDA
GOOG
MSFT
SPCE
RKLB
GD
BA
AMD
INTC
META
CRWD
PLTR
AN
DD
HON
RTX
IBM
AMZN
TSLA
XOM
CVX
UNH
BMY
PFE
MRK
JNJ
LLY
GILD
REGN
BIIB
AMGN
AZN
NVO
SNY
TEVA
BABA
JD
NTES
BIDU
IQ
VIPS
BZUN
HTHT
MELI
BBD
BB
ERIC
NOK
QCOM
MU
ADSK
CRM
GOOGL
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
Alpha Thalassemia (US, EU4, UK, and Japan) Market Insights, Epidemiology, and Forecasts 2022-2025 & 2025-2036
globenewswire.com
AGIO
NVO
Global Weight Loss and Obesity Management Market | 12.8% CAGR Growth Trajectory | Asia Pacific, North America Lead | Novo Nordisk, Eli Lilly, Medtronic Drive Integrated Care Evolution
prnewswire.com
NVO
LLY
MDT
2026 Top Trends in Snacks and Confectionery: GLP-1 Medications Such as Ozempic has Heightened the Significance of the "Snack As the New Meal" Trend
globenewswire.com
NVO
Choose Health Launches Comprehensive At-Home GLP-1 Monitoring Panels for Ozempic, Wegovy and Mounjaro Users
prnewswire.com
NVO
LLY
Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU
globenewswire.com
NVO
92% Awareness, 38% Interest Signal Next Wave of GLP-1 Adoption, Reach3 Insights Study Finds
prnewswire.com
LLY
NVO
KO
PEP
Novi Weight Loss GLP-1 Program (2026): What 50,000 People Searching This Brand Need to Know Before Enrolling
accessnewswire.com
NVO
LLY
Novo Nordisk's Wegovy® HD available now nationwide
prnewswire.com
NVO